Mathematical modeling of CA125 kinetics in recurrent ovarian cancer (ROC) patients treated with chemotherapy and predictive value of early modeled kinetic parameters in CALYPSO trial: A GCIG study.

Benoit You,Olivier Colomban,Mark Heywood,Chee Lee,Margaret Davy,Nick Reed,Sandro Pignata,Roldano Fossati,Günter Emons,K. L. Rehman,Karina Dahl Steffensen,Edgar Petru,Val Gebski,Alexander Burges,N. Tubiana-Matthieu,M. Hansen,P. Vasey,U Denison,P. de Bruyne,Amit M. Oza

Mathematical modeling of CA125 kinetics in recurrent ovarian cancer (ROC) patients treated with chemotherapy and predictive value of early modeled kinetic parameters in CALYPSO trial: A GCIG study.

2011

5065 Background: Although CA125 kinetic profiles may be related with relapse risk in ovarian cancer patients treated with chemotherapy, no reliable kinetic parameters have been reported. Mathematic...

Keywords:

Oncology
Pathology
Chemotherapy
Recurrent Ovarian Cancer
Internal medicine
Surgery
Medicine
Ovarian cancer
relapse risk
predictive value

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations